
|Articles|April 24, 2006
Accredo wins Flolan agreement
Accredo Health Group, a subsidiary of Medco, won a five-yearcontract as the sole specialty pharmacy for Flolan (epoprostenolsodium, Myogen) for pulmonary arterial hypertension (PAH). Terms ofthe deal were not announced.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
2
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
3
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
4
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
5




















































































































































